• Issla Fisher posted an update in the group Group logo of ProductProduct 11 months ago

    The US FDA Has Approved The First Long-Acting Injectable HIV PrEP Medication. The Drug, Called Apretude, Given To Patients Every 2 Months, Is Said To Be 69% More Effective Than The Daily HIV Prevention Pills, Like Truvada and Descovy, For Cisgender Men And Transgender Women Who Have Sex With Men, And 90% More Effective For Cisgender Women.

About us   |  FAQ  |  Contact us   |  Copyright ©2022  DiscoveryBit.com  |   Privacy  |   Terms of Service

   
Do NOT follow this link or you will be banned from the site! This is a social network for those interested in unique and valuable information!

Log in with your credentials

or    

Forgot your details?

Create Account